CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma.

Date Published

October 23, 2023

Ciulean IS, Fischer J, Quaiser A, Bach C, Abken H, Tretbar US, Fricke S, Koehl U, Schmiedel D, Grunwald T. CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma. Front Immunol. 2023 14:1290488. doi:10.3389/fimmu.2023.1290488. PMID: 38022580